Synthesis of Enantiopure Conduritols
J . Org. Chem., Vol. 66, No. 13, 2001 4633
portions to a slurry of the polyol (10.0 mmol) in redistilled
pyridine (35 mL) at 90 °C over 2-5 h. The solution was then
cooled to 0 °C before benzoyl chloride (10.5 mL, 90.0 mmol)
was added. After the solution was stirred for 48 h at room
temperature, the crude product was poured into a mixture of
EtOH (60 mL) and ice (30 mL) and stirred for 2 h to provide
a solid that was filtered off.
131.2, 129.7-128.2 (20C), 120.9, 120.8, 73.6, 73.4, 71.4, 71.2.
Anal. Calcd for C36H30O8: C, 73.21; H, 5.12. Found: C, 73.36;
H, 5.47.
3,4,5,6-Tet r a -O-b en zoyl-1,2,7,8-t et r a d eoxy-L-m a n n o-
octa -1,7-d ien itol (11). Prepared from dibromide 9 as de-
scribed above for 10. Rf ) 0.50 (hexane/EtOAc ) 3:1). [R]D:
1
-80.0 (c 2, CHCl3). H NMR (CDCl3, 300 MHz): δ 8.08 (dd, J
) 7.4, 0.6 Hz, 4H), 7.96 (dd, J ) 7.3, 1.5 Hz, 4H), 7.55 (dt, J
) 7.6, 1.5 Hz, 2H), 7.50 (dd, J ) 8.0, 0.6 Hz, 2H), 7.41 (dd, J
) 7.6, 7.4 Hz, 4H), 7.32 (dd, J ) 8.0, 7.3 Hz, 4H), 6.06 (ddd, J
) 17.3, 10.4, 6.9 Hz, 2H), 5.96 (d, J ) 5.2 Hz, 2H), 5.87 (m,
2H), 5.55 (d, J ) 17.4 Hz, 2H), 5.38 (d, J ) 10.4 Hz, 2H). 13C
NMR (CDCl3, 75 MHz): δ 165.2 (2C), 165.0 (2C), 133.1 (2C),
132.9 (2C), 131.3 (2C), 129.7 (4C), 129.6 (6C), 129.5 (2C), 128.3-
(4C), 128.2 (4C), 121.0 (2C), 73.5 (2C), 70.9 (2C). Anal. Calcd
for C36H30O8: C, 73.21; H, 5.12. Found: C, 72.86; H, 5.00.
2,3,4,5,6-P en ta -O-ben zoyl-1,7-d i-O-tr ip h en ylm eth yl-D-
glycer o-D-gu lo-h ep titol (14). Rf ) 0.42 (hexane/EtOAc ) 7:2).
2,3,4,5,6,7-Hexa -O-ben zoyl-1,8-d i-O-tr ip h en ylm eth yl-D-
er yth r o-L-ga la cto-octitol (6). Rf ) 0.47 (hexane/EtOAc )
2:1). Mp: 98-100 °C (CHCl3/EtOH). [R]D: +3.5 (c 2, CHCl3).
1H NMR (CDCl3, 300 MHz): δ 8.25-6.85 (m, 60H), 6.16 (dd,
J ) 8.2, 4.1 Hz, 1H), 6.09 (dd, J ) 6.6, 3.9 Hz, 1H), 6.05 (dd,
J ) 6.4, 3.0 Hz, 1H), 5.99 (t, J ) 4.0 Hz, 1H), 5.81 (ddd, J )
8.8, 5.8, 3.2 Hz, 1H), 5.58 (ddd, J ) 7.7, 4.3, 2.7 Hz, 1H), 3.40-
3.05 (m, 4H). 13C NMR (CDCl3, 75 MHz): δ 165.1, 165.0 (2C),
164.8 (2C), 164.6, 143.2 (6C), 132.7-132.5 (6C), 129.8-126.6
(60C), 86.8, 86.5, 71.6, 70.9, 70.8, 70.0 (2C), 69.2, 62.1, 61.9.
Anal. Calcd for C88H70O14: C, 78.21; H, 5.22. Found: C, 77.99;
H, 5.24.
1
Mp: 111-112 °C (CHCl3/EtOH). H NMR (CDCl3, 250 MHz):
δ 7.87-6.96 (m, 55H), 6.33 (dd, J ) 7.6, 4.4 Hz, 2H), 5.96 (t,
J ) 4.4 Hz, 1H), 5.56 (ddd, J ) 7.6, 4.7, 3.4 Hz, 2H), 3.45 (dd,
J ) 10.5, 4.7 Hz, 2H), 3.29 (dd, J ) 10.5, 3.4 Hz, 2H). 13C NMR
(CDCl3, 75 MHz): δ 165.0, 164.9 (2C), 164.8 (2C), 143.2 (6C),
132.8-126.6 (60C), 86.6 (2C), 71.4 (2C), 69.6 (2C), 69.5, 61.9
(2C). Anal. Calcd for C80H64O12: C, 78.93; H, 5.30. Found: C,
78.79; H, 5.45.
2,3,4,5,6-P en ta -O-ben zoyl-1,7-d i-O-tr ip h en ylm eth yl-D-
glycer o-D-ga la cto-h ep titol (15). Rf ) 0.62 (hexane/EtOAc )
2:1). Mp: 173-176 °C (CHCl3/EtOH). [R]D: +21.4 (c 1.7,
CHCl3). 1H NMR (CDCl3, 500 MHz): δ 7.91-7.82 (m, 10H),
7.55-7.42 (m, 5H), 7.35-7.24 (m, 22H), 7.05-6.95 (m, 18H),
6.20 (dd, J ) 7.8, 1.8 Hz, 1H), 6.04 (dd, J ) 6.9, 1.8 Hz, 1H),
5.94 (dd, J ) 6.9, 2.9 Hz, 1H), 5.79 (m, 1H), 5.53 (m, 1H), 3.40
(dd, J ) 10.8, 3.2 Hz, 1H), 3.36 (dd, J ) 9.8, 6.9 Hz, 1H), 3.24
(dd, J ) 9.9, 5.5 Hz, 1H), 3.21 (dd, J ) 10.9, 5.3 Hz, 1H). 13C
NMR (CDCl3, 75 MHz): δ 165.1 (2C), 165.0, 164.7, 164.5, 143.3
(6C), 132.9, 132.8 (2C), 132.7, 132.6, 129.8-126.6 (55C), 86.8,
86.6, 71.1, 70.7, 70.1, 69.2, 69.1, 62.0 (2C). Anal. Calcd for
2,3,4,5,6,7-Hexa -O-ben zoyl-1,8-d i-O-tr ip h en ylm eth yl-D-
th r eo-L-ga la cto-octitol (7). Rf ) 0.51 (hexane/EtOAc ) 2:1).
Mp: 118-120 °C (CHCl3/EtOH). [R]D: -12.5 (c 2.0, CHCl3).
1H NMR (CDCl3, 300 MHz): δ 7.89 (d, J ) 7.6 Hz, 4H), 7.82
(d, J ) 7.5 Hz, 4H), 7.68 (d, J ) 7.4 Hz, 4H), 7.49-7.35 (m,
6H), 7.30-7.17 (m, 24H), 7.03-6.98 (m, 18H), 6.04 (d, J ) 5.2
Hz, 2H), 5.98 (dd, J ) 5.2, 2.6 Hz, 2H), 5.78 (ddd, J ) 6.4, 6.1,
2.6 Hz, 2H), 3.27 (dd, J ) 9.4, 6.4 Hz, 2H), 3.12 (dd, J ) 9.4,
6.1 Hz, 2H). 13C NMR (CDCl3, 75 MHz): δ 165.0 (4C), 164.7
(2C), 143.2 (6C), 132.8 (2C), 132.6 (2C), 132.5 (2C), 129.9-
126.6 (60C), 86.7 (2C), 70.8 (2C), 70.7 (2C), 70.4 (2C), 61.6 (2C).
Anal. Calcd for C88H70O14: C, 78.21; H, 5.22. Found: C, 77.98;
H, 5.22.
Gen er a l P r oced u r e for Br om in a tion (Sch em e 2). The
ditrityl compound (1.5 mmol) was treated with 32% HBr in
AcOH (20 mL) in a closed flask for 7 days. The mixture was
diluted with CH2Cl2 (50 mL) and washed with H2O (200 mL)
and 5% aqueous NaHCO3 (3 × 200 mL). The organic phase
was dried and concentrated and the residue purified by flash
chromatography.
C
80H64O12: C, 78.93; H, 5.30. Found: C, 78.67; H, 5.42.
2,3,4,5,6-P en t a -O-b en zoyl-1,7-d ib r om o-1,7-d id eoxy-D-
2,3,4,5,6,7-Hexa -O-ben zoyl-1,8-d ibr om o-1,8-d id eoxy-D-
er yth r o-L-ga la cto-octitol (8). Rf ) 0.46 (hexane/EtOAc )
glycer o-D-gu lo-h ep titol (16). Rf ) 0.64 (hexane/EtOAc ) 2:1).
Mp: 158-160 °C (Et2O). 1H NMR (CDCl3, 300 MHz): δ 7.96-
7.82 (m, 10H), 7.56-7.38 (m, 5H), 7.37-7.22 (m, 10H), 6.16-
6.04 (m, 3H), 5.68 (dd, J ) 10.9, 5.1 Hz, 2H), 3.79 (dd, J )
11.4, 4.4 Hz, 2H), 3.63 (dd, J ) 11.4, 5.3 Hz, 2H). 13C NMR
(CDCl3, 75 MHz): δ 165.1, 164.9 (4C), 133.2 (5C), 129.8 (4C),
129.7, 128.3-128.0 (20C), 70.9 (4C), 68.5, 30.0 (2C). Anal.
Calcd for C42H34O10Br2: C, 58.76; H, 3.99. Found: C, 58.80;
H, 3.86.
1
2:1). [R]D: +5.58 (c 1, CHCl3). H NMR (CDCl3, 250 MHz): δ
8.21-7.10 (m, 30H), 6.20-6.00 (m, 4H), 5.68 (dt, J ) 6.4, 2.3
Hz, 1H), 5.59 (ddd, J ) 6.9, 4.4, 4.1 Hz, 1H), 3.71 (dd, J )
11.5, 4.1 Hz, 1H), 3.65-3.38 (m, 3H). 13C NMR (CDCl3, 75
MHz): δ 165.1, 165.0 (4C), 164.8, 133.5, 133.2 (2C), 133.0 (3C),
130.1-127.8 (30C), 71.0, 70.8 (2C), 70.6, 69.0, 68.7, 30.1, 29.0.
Anal. Calcd for C50H40O12Br2: C, 60.50; H, 4.06; Br, 16.10.
Found: C, 60.95; H, 4.20; Br, 15.94.
2,3,4,5,6-P en t a -O-b en zoyl-1,7-d ib r om o-1,7-d id eoxy-D-
glycer o-D-ga la cto-h ep titol (17). Rf ) 0.60 (hexane/EtOAc )
2,3,4,5,6,7-Hexa -O-ben zoyl-1,8-d ibr om o-1,8-d id eoxy-D-
th r eo-L-ga la cto-octitol (9). Rf ) 0.53 (hexane/EtOAc ) 3:1).
Mp: 152-155 °C (hexane/EtOAc). [R]D: +12.7 (c 1.5, CHCl3).
1H NMR (CDCl3, 300 MHz): δ 7.96-7.83 (m, 12H), 7.54-7.41
(m, 6H), 7.36-7.22 (m, 12H), 6.07 (d, J ) 6.6 Hz, 2H), 6.03
(dd, J ) 6.6, 2.6 Hz, 2H), 5.67 (ddd, J ) 6.6, 6.2, 2.6 Hz, 2H),
3.56 (dd, J ) 10.8, 6.2 Hz, 2H), 3.50 (dd, J ) 10.8, 6.6 Hz,
2H). 13C NMR (CDCl3, 75 MHz): δ 165.1 (2C), 164.9 (4C), 133.2
(4C), 133.0 (2C), 129.8-128.1 (30C), 71.2 (2C), 70.7 (2C), 69.5
(2C), 28.9 (2C). Anal. Calcd for C50H40O12Br2: C, 60.50; H, 4.06;
Br, 16.10. Found: C, 60.18; H, 4.13; Br, 16.05.
3,4,5,6-Tetr a -O-ben zoyl-1,2,7,8-tetr a d eoxy-D-gu lo-octa -
1,7-d ien itol (10). Dibromide 8 (0.33 g, 0.33 mmol) was
dissolved in a mixture of EtOAc (3 mL), H2O (1 mL), and AcOH
(6 mL). Activated zinc9a (1.00 g, 15.3 mmol) was added and
the mixture sonicated for 3 h. The precipitate was filtered off
and washed with H2O and CH2Cl2. The filtrate was diluted
with CH2Cl2 (60 mL) and washed with H2O (25 mL) and 5%
aqueous NaHCO3 (50 mL). The organic layer was dried and
concentrated and the residue purified by flash chromatography
(hexane/EtOAc ) 3:1) to provide 0.20 g (99%) of 10 as a foam.
Rf ) 0.35. [R]D: -27.2 (c 1, CHCl3). 1H NMR (CDCl3, 300
MHz): δ 8.15-7.88 (m, 8H), 7.66-7.27 (m, 12H), 6.09-5.81
(m, 6H), 5.53-5.27 (m, 4H). 13C NMR (CDCl3, 75 MHz): δ
165.3, 165.2, 165.1, 164.9, 133.3, 133.1, 132.9 (2C), 131.5,
1
2:1). Mp: 138-142 °C (EtOH). [R]D: +3.3 (c 1.7, CHCl3). H
NMR (CDCl3, 500 MHz): δ 8.08-7.79 (m, 10H), 7.59-7.19 (m,
15H), 6.08-6.02 (m, 3H), 5.71 (dt, J ) 6.3, 2.1 Hz, 1H), 5.64
(dt, J ) 6.1, 4.9 Hz, 1H), 3.79 (dd, J ) 11.4, 4.5 Hz, 1H), 3.62-
3.53 (m, 3H). 13C NMR (CDCl3, 125 MHz): δ 165.1-164.9 (5C),
133.5, 133.4 (2C), 133.2, 133.1, 130.0-128.1 (25C), 71.1, 70.8,
70.2, 70.0, 68.6, 29.8, 28.9. Anal. Calcd for C42H34O10Br2: C,
58.76; H, 3.99; Br, 18.61. Found: C, 59.02; H, 3.83; Br, 18.39.
4,5-O-Isop r op ylid en e-1,2,7,8-tetr a d eoxy-L-m a n n o-octa -
1,7-d ien itol (19). To a solution of L-tartrate 18 (2.5 g, 11.5
mmol) in toluene (20 mL) at -78 °C was added a 1.2 M solution
of Dibal-H in toluene (22 mL, 26.4 mmol) over 5 min. The
mixture was stirred at -78 °C for 2 h followed by dropwise
addition of a 0.5 M solution of divinylzinc9a in THF (92 mL,
46 mmol) over 20 min. The stirring was continued for 1 h at
-78 °C, and the solution was then allowed to warm to room
temperature. The mixture was carefully quenched with H2O
(10 mL) followed by addition of a saturated aqueous solution
of Rochelle salt (100 mL) and EtOAc (100 mL). After the
mixture was stirred for 30 min, the phases were separated
and the aqueous phase was extracted with EtOAc (3 × 100
mL). The combined organic phases were dried and concen-
trated. The residue was purified by flash chromatography
(hexane/EtOAc ) 2:1) to afford 2.03 g (83%) of 19 as a syrup.